无标记数据非依赖采集质谱技术分析B型钠尿肽杂质
该研究采用超高效液相色谱-高分辨质谱联用技术鉴定合成BNP中的杂质(BNPstrimp化合物),并建立无标记数据非依赖采集(DIA)质谱定量方法,结合同位素稀释质谱(ID-MS)进行绝对定量。在合成BNP中鉴定出17种BNPstrimp化合物,其中10种成功测序;脱酰胺、氧化和异构化BNPstrimp化合物的免疫亲和力弱于完整BNP1-32。该方法简便、准确,适用于良好分离条件下低丰度BNPstrimp化合物的平行定量,定量结果可比且可溯源。
要点
- 合成BNP中鉴定出17种BNPstrimp杂质,10种完成测序。
- 脱酰胺、氧化和异构化BNPstrimp免疫亲和力弱于完整BNP1-32。
- 建立的无标记DIA质谱法可平行定量低丰度BNP杂质。
核心结论
- 所建立的无标记DIA质谱方法简便、准确,适用于良好液相分离条件下低丰度BNPstrimp化合物的平行定量,定量结果可比且可溯源。
研究设计与样本
- 采用超高效液相色谱-高分辨质谱联用技术分离鉴定合成BNP中的BNPstrimp化合物,并建立无标记DIA质谱定量方法,结合ID-MS进行绝对定量,方法精密度用C肽参考物质考察。
主要发现
- 在合成BNP中鉴定出17种BNPstrimp化合物,其中10种成功测序。
- 免疫印迹(WB)结果显示,脱酰胺、氧化和异构化BNPstrimp化合物的免疫亲和力弱于完整BNP1-32。
- 经ID-MS定量,合成固体内标肽ISP1-16的质量分数为853.5(±17.8)mg/g。
关键数值与推荐
- 合成固体内标肽ISP1-16经ID-MS定量的质量分数为853.5(±17.8)mg/g。
临床怎么用
- 该方法可用于BNP产品质量与安全性评估,有助于减少临床测量误差并提高药物安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Synthetic B-type natriuretic peptide (BNP) is employed in most clinical testing platforms as a raw material of calibrator. Characterization of impurities with structures similar (BNPstrimp compounds) to that of BNP is a reasonable way to decrease clinical measurement errors and improve drug safety. METHODS: A novel quantitative method targeted towards BNPstrimp compounds was developed. First, the peptide samples were separated and identified using ultra-performance liquid chromatography, coupled with high-resolution mass spectrometry (MS). To evaluate biological activity further, BNPstrimp immunoaffinity was investigated using western blot (WB) assays. Second, a quantitative label-free data-independent acquisition (DIA) MS approach was developed, and the internal standard peptide (ISP) was hydrolyzed. Absolute quantification was performed using an isotope dilution MS (ID-MS) approach. Third, method precision was investigated using the C-peptide reference material. RESULTS: Seventeen BNPstrimp compounds were identified in synthetic BNP, and 10 of them were successfully sequenced. The immunoassay results indicated that deaminated, oxidized, and isomerized BNPstrimp compounds exhibited weaker immunoaffinity than intact BNP1-32. The mass fraction of the synthetic solid ISP1-16, quantified by ID-MS, was 853.5 (±17.8) mg/g. Validation results indicated that the developed method was effective and accurate for the quantitation of the well-separated BNP impurities. CONCLUSIONS: The developed approach was easy to perform, and it was suitable for the parallel quantification of low-abundance BNPstrimp compounds when they performed a good separation in liquid chromatography. The quantitative results were comparable and traceable. This approach is a promising tool for BNP product quality and safety assessment.
引用
- Xiao P, Zhang F, Wang X, et al. Analysis of B-type natriuretic peptide impurities using label-free data-independent acquisition mass spectrometry technology. Clin Chem Lab Med. 2020. PMID: 32716903. doi:10.1515/cclm-2020-0012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。